21st Century Oncology
21st Century Oncology operates an international medical tourism referral portal connecting cancer patients with accredited treatment hospitals in Germany, Israel, Turkey, Spain, Czech Republic, and South Korea, monetized through affiliate lead generation and SEO-driven content marketing.
- Company typePrivate
- Founded1983
- HeadquartersFort Myers, United States
- Headcount1,001–5,000
- GTM typeB2C
- OfferingDigital Commerce or Content
What 21st Century Oncology does
21st Century Oncology presents two distinct identities in the source data. Per firmographic inputs, it is a US for-profit cancer care provider founded in 1983 in Fort Myers, Florida, previously listed on NASDAQ under ticker RTSX, with 1,001-5,000 employees and a $325 million funding round from CPP Investments in 2014 alongside a recorded acquisition of OnCURE Medical in 2013. Historical leadership includes Daniel E. Dosoretz (CEO & Co-Founder), Daniel H. Galmarini (CTO), and Gary Delanois (SVP of Multispecialty Operations).
The currently observable asset — the 21stcenturyoncology.com domain — operates as an international medical tourism information and referral portal rather than a clinical care provider. The site connects patients with oncology treatment facilities across six countries: Germany (Helios Berlin-Buch, Asklepios Barmbek, Bremen-Mitte), Israel (Suraski/Ichilov), Turkey (Anadolu Medical Center), Spain, Czech Republic, and South Korea. The platform publishes educational content on treatment modalities including surgery, radiation therapy (CyberKnife, IORT, HIFU), chemotherapy (HIPEC, PIPAC), immunotherapy, targeted therapy, CAR-T therapy, hormone therapy, stem cell transplant, and chemoembolization.
The business model is an affiliate/referral lead-generation model: patient inquiries submitted via a contact form are routed to partner hospitals. Distribution is content-marketing and SEO-driven, with supplementary social presence on Facebook, Twitter, Instagram, and YouTube under the #TreatingCancer hashtag. No pricing is publicly disclosed. Importantly, the homepage prominently displays paid text-link advertisements for unrelated products (anabolic steroids, sports betting, surrogacy services, marijuana seeds, mattresses, aesthetic clinics), and the site runs on a WordPress "ShopUp Lite" theme — signals that the domain is also being monetized as a low-quality link-selling content property. No parent company, ownership structure, or relationship between the historic US oncology operator and the current international referral site is disclosed in the source materials.
21st Century Oncology firmographics
Firmographics- Name
- 21st Century Oncology
- Legal name
- 21st Century Oncology
- Website
- https://21stcenturyoncology.com
- Company type
- Private
- Founded year
- 1983
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- 21st Century Oncology operates an international medical tourism referral portal connecting cancer patients with accredited treatment hospitals in Germany, Israel, Turkey, Spain, Czech Republic, and South Korea, monetized through affiliate lead generation and SEO-driven content marketing.
- Ownership category
- akta.pro rank
Where 21st Century Oncology is headquartered
LocationHeadquarters
- HQ city
- Fort Myers
- HQ country
- United States
- HQ region
- North America
Markets served
21st Century Oncology business model
Business model- GTM type
- B2C
- Offering type
- Digital Commerce or Content
- Cost components
- Marketing or Sales, Personnel, Technology or R&D, Operations
Revenue model
- Hospital Referral/Lead Generation: The company appears to generate revenue through referrals and lead generation for partner hospitals and treatment facilities. Patients inquiring through the platform are connected with partner hospitals for consultation and treatment.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
21st Century Oncology product offering
Product offeringCore offering
21st Century Oncology operates an online medical tourism information portal that connects international cancer patients with accredited oncology treatment providers in Germany, Israel, Turkey, Spain, Czech Republic, and South Korea. The platform publishes educational content about cancer therapies (chemoembolization, HIFU, immunotherapy, targeted therapy, CAR-T, radiation, surgery) and profiles partner hospitals, then routes patient inquiries to those partner facilities for consultation and treatment.
Product overview
21st Century Oncology operates as a medical tourism information portal connecting international patients with cancer treatment providers across multiple countries. The platform aggregates hospital partnerships in Germany (Helios Berlin-Buch, Asklepios Barmbek, Bremen-Mitte), Israel (Ichilov/Suraski), and Turkey (Anadolu Medical Center). The service offers educational content about various oncology treatments including surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, hormone therapy, stem cell transplant, chemoembolization, HIFU therapy, and CAR-T cell therapy. The core platform provides information about cancer types, treatment options, and prevention strategies, functioning as a directory and educational resource rather than a direct medical service provider.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Tourism Oncology Information Portal An online healthcare information platform that connects international cancer patients with oncology treatment providers across Germany, Israel, Turkey, Spain, Czech Republic, and South Korea. The portal provides hospital profiles, treatment information, and an inquiry form that routes patients to partner facilities.
Quantifiable outcome
- Featured hospitals treat over 400,000 patients annually at leading facilities like Suraski Medical Center
- +2 more outcomes
Companies that use 21st Century Oncology
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles1 record
21st Century Oncology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
21st Century Oncology partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- Anadolu Medical CentercoreAnadolu Medical Center is a leading multi-specialty cancer center in Turkey affiliated with Johns Hopkins Hospital. The partnership provides patients access to advanced treatments including CyberKnife M6, Varian Edge, and TrueBeam STx radiation systems. Anadolu has OECI accreditation and ESMO certification.
- Bremen-Mitte HospitalcoreBremen-Mitte is a multidisciplinary medical center treating 40,000 patients annually. The cancer center is certified by German Cancer Society (DKG) and European Cancer Society (ECC). Offers advanced treatments including NEOliquid liquid biopsy and HIPEC therapy.
- Helios Clinic Berlin-BuchcoreHelios Berlin-Buch is one of Germany's largest hospitals with over 200,000 patients annually, designated a cancer center by German Cancer Society (DKG). Offers IORT, HIPEC, PIPAC, and RFA treatments. Ranked by Focus magazine and Newsweek in 2021.
- Asklepios Klinik BarmbekcoreAsklepios Klinik Barmbek is part of Germany's largest hospital network, treating over 80,000 patients annually. Its oncology clinic is DKG-accredited. Features Da Vinci Robot, Gamma-knife, and VATS for advanced treatments. Ranked top 5 by MTQA.
- Suraski Medical Center (Ichilov)coreIchilov is a leading multi-specialty clinic in Israel, seeing over 400,000 patients and performing 34,000 operations annually. Ranked top 3 in Israel by Newsweek 2021. Features Novalis TrueBeam STx, Da Vinci robotic system, and CAR-T therapy.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
21st Century Oncology competitors and assessment
Company assessmentDirect peers
- Medigo (Allianz Care): Medigo (now part of Allianz Care) is a medical tourism marketplace that helps international patients find and book treatment at accredited providers. It is directly comparable in intermediary model, content-driven discovery, and multi-country specialty hospital network.
- BookingHealth: BookingHealth is a medical tourism platform that connects international patients with hospitals and clinics across multiple countries, including Germany and Israel. It mirrors 21st Century Oncology in business model (digital intermediary + lead generation) and target audience (cross-border patients seeking specialty treatment).
- Treatment in Germany: Treatment in Germany is a medical tourism facilitator focused on routing international patients to German hospitals for oncology, cardiology, and other specialty care. It is highly comparable in country focus (Germany), partner type (DKG-accredited hospitals), and patient acquisition approach (content + SEO).
- Qunomedical: Qunomedical is a digital health platform that connects patients with vetted clinics and hospitals worldwide, with a strong oncology and specialty focus. It is comparable as a content-and-concierge medical tourism intermediary for international patients.
- Clinic Hunter: Clinic Hunter is a European medical tourism platform focused on connecting international patients with clinics and hospitals for specialty treatments. It is comparable in intermediary role, European hospital network, and content-led patient acquisition.
- MyMeditravel: MyMeditravel is a medical tourism platform offering treatment packages across multiple countries and specialties. It is comparable as a content-driven, lead-generation intermediary linking international patients with overseas specialty hospitals.
- Medical Departures: Medical Departures is a global medical tourism marketplace with verified provider listings, reviews, and booking support. It is directly comparable in business model (intermediary + verified providers) and cross-border specialty focus.
- Healthbase: Healthbase is a US-based medical tourism facilitator connecting international patients with partner hospitals abroad. It shares the same US-domestic operating base, intermediary model, and multi-country specialty hospital network.
- TourMedical: TourMedical is a medical tourism agency that arranges treatment and travel packages for patients seeking care abroad, with strong Turkey and Europe coverage. It is directly comparable as a cross-border oncology referral platform.
Others
- Springer Nature: Springer Nature publishes peer-reviewed oncology content and clinical decision-support resources that international cancer patients and clinicians use. It is comparable to 21st Century Oncology only in the content and educational layer of its offering, not in patient referrals or commercial transactions.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key highlights5 records
Customer concentration
21st Century Oncology social profiles
Digital presence21st Century Oncology compliance and trust
Trust signalCompliance7 records
21st Century Oncology financial estimates
Financial estimateRevenue estimate
Valuation estimate
21st Century Oncology leadership team
Management profileNumber of profiles
Profiles3 records
21st Century Oncology funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
21st Century Oncology M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 21st Century Oncology
What does 21st Century Oncology do?
21st Century Oncology operates an online medical tourism information portal that connects international cancer patients with accredited oncology treatment providers in Germany, Israel, Turkey, Spain, Czech Republic, and South Korea. The platform publishes educational content about cancer therapies (chemoembolization, HIFU, immunotherapy, targeted therapy, CAR-T, radiation, surgery) and profiles partner hospitals, then routes patient inquiries to those partner facilities for consultation and treatment.
Is 21st Century Oncology a public or private company?
21st Century Oncology is a private company. It is classified as venture growth investor backed and is currently operating.
When was 21st Century Oncology founded?
21st Century Oncology was founded in 1983. It employs 1,001 to 5,000 people.
Where is 21st Century Oncology based?
21st Century Oncology is headquartered in Fort Myers, United States, in the North America region.
How does 21st Century Oncology make money?
One revenue line is on record: hospital Referral/Lead Generation.
Who are 21st Century Oncology's main competitors?
Direct peers on record are Medigo (Allianz Care), BookingHealth, Treatment in Germany, Qunomedical, Clinic Hunter, MyMeditravel, Medical Departures, Healthbase and TourMedical. Springer Nature is listed as an others.
Does 21st Century Oncology have an API?
No public API is recorded for 21st Century Oncology.